Minerva Neurosciences Elects William Doyle and Hans Peter Hasler to Board of Directors
December 11, 2017 08:15 ET
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...